Give the gift of LIFE! Support the Population Research Institute!

Only $106,679 to go!

Topics: Steven Condly

New PRI Study Shows Depo-Provera Increases Risk of HIV Infection



A new peer-reviewed study,1 conducted in collaboration with the Population Research Institute (PRI), shows that women who use Depo-Provera are significantly more likely to acquire HIV. Due to funding from organizations like the Bill and Melinda Gates Foundation and agencies like the United Nations Population Fund (UNFPA), Depo-Provera is the most widely used form of birth control by women in Sub-Saharan Africa where HIV prevalence remains high. The study found that Depo-Provera and other DMPA …

Read more.




New Study Shows Risk of HIV Acquisition Is Higher with DMPA Contraceptives



A review and meta-analysis has found that women who use depot medroxyprogesterone acetate (DMPA), the active ingredient in injectable contraceptives like Depo-Provera, are placed at a significantly higher risk of acquiring HIV. The findings could have a deep residual impact for many women who depend on DMPA for contraception and are living in developing countries or in at-risk environments where the risk of HIV transmission remains high. Joel Brind, Professor of Biology and Endocrinology at …

Read more.




Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.